3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Nasopharyngeal Carcinoma
4
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Initiation and Maintenance Disorders
1
Sarcoma, Ewing
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Locally Advanced Resectable Rectal Cancer
1
Leukemia, Biphenotypic, Acute
1
Gastric Cancer With Liver Metastases
1
Endometrial Neoplasms
1
Advanced Solid Tumors
1
Advanced Solid Tumor
1
Interventions
Magnetic Resonance Spectroscopy
28
enzalutamide
23
Specimen Handling
20
apalutamide
17
Androgen Antagonists
14
Radiosurgery
13
Radiotherapy
12
Prednisone
12
Docetaxel
12
Abiraterone Acetate
12
abiraterone
10
Biopsy
10
Radiation
8
niraparib
6
luprolide acetate gel depot
6
darolutamide
6
Pluvicto
6
Leuprolide
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
relugolix
5
gallium 68 PSMA-11
5
cabazitaxel
5
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
5
Nivolumab
5
Gonadotropin-Releasing Hormone
5
bicalutamide
4
Triptorelin Pamoate
4
Surveys and Questionnaires
4
Radiotherapy, Intensity-Modulated
4
Glutamate Carboxypeptidase II
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Drug Therapy
×
30 days
×
Clear all
No trials found.